FINAL BILL REPORT
E2SSB 5395
C 157 L 26
Synopsis as Enacted
Brief Description: Making improvements to transparency and accountability in the prior authorization determination process.
Sponsors: Senate Committee on Ways & Means (originally sponsored by Senators Orwall, Muzzall, Hasegawa, Lovelett, Nobles and Slatter).
Senate Committee on Health & Long-Term Care
Senate Committee on Ways & Means
House Committee on Health Care & Wellness
House Committee on Appropriations
Background:

Prior authorization is the requirement that a health care provider seek approval of a drug, procedure, or test before receiving reimbursement from a health carrier. Health carriers may impose different prior authorization standards and criteria for a covered service among tiers of contracting providers. In 2023, the Legislature passed HB 1357, establishing timeframes for standard and expedited prior authorization requests for health plans offered by health carriers; health plans offered to public or school employees, retirees, and their dependents; and Medicaid coverage offered through managed care organizations. 

 

Health carriers, health plans, and managed care organizations must describe their prior authorization requirements in detailed, easily understandable language. Health carriers, health plans, and managed care organizations must make the most current prior authorization requirements and restrictions available upon request in an electronic format. The prior authorization requirements must be based on peer-reviewed, evidence-based clinical review criteria which is evaluated and updated at least annually. The clinical review criteria must accommodate new and emerging information related to the appropriateness of clinical criteria with respect to Black and Indigenous people, other people of color, gender, and underserved populations.

 

Health carriers, health plans, and managed care organizations must build and maintain a prior authorization application programming interface that automates the process for determining the necessity for a prior authorization, identifying information and documentation requirements, and facilitating the exchange of prior authorization requests and determinations. The application programming interface must use Health Level 7 Fast Healthcare Interoperability Resources, automate the prior authorization determination process, allow providers to query prior authorization documentation requirements, support automated compiling and exchange of necessary data elements to populate the prior authorization requirements, and indicate that prior authorization denials or authorizations of less intensive services are adverse benefit determinations subject to grievance and appeal processes. As an alternative to using an application programming interface, health carriers, health plans, and managed care organizations may establish an interoperable electronic process for prior authorizations related to prescription drugs. 

 

The application programming interface must support prior authorization requests and determinations for health care services beginning January 1, 2025, and for prescription drugs beginning January 1, 2027. If federal regulations on the application programming interface standards are not finalized by September 13, 2023, the commencement date for standards related to health care services will be delayed until January 1, 2026.

 

By October 1, 2020, and annually thereafter, for individual and group health plans issued by a carrier that has written at least 1 percent of the total accident and health insurance premiums written by all companies authorized to offer accident and health insurance in Washington in the most recently available year, the carrier must report to the Office of the Insurance Commissioner (OIC) certain prior authorization data for the prior plan year related to procedures and services with the highest number of requests, approvals, and denials. 

Summary:

Prior Authorization Requirements. When issuing a notification for a prior authorization determination, the carrier or health plan, and contracted health care benefit managers must provide the credentials, board certifications, and areas of specialty of the provider who had clinical oversight over the determination in any notification sent to the health plan enrollee and provider requesting or referring the service.

 

Carriers and health plans must post any adjustments to policies and procedures that impact the applicability of their prior authorization requirements for health care services or prescription drugs, including new applications of prior authorization, in a single location on their website. After December 30, 2030, any new application of prior authorization for health care services must be available to providers on the electronic prior authorization system or application programming interface system.

 

Artificial Intelligence.  A determination of medical necessity shall be made only by a licensed physician or a licensed health professional working within their scope of practice. The licensed physician or licensed health professional shall evaluate the specific clinical issues involved in the health care services requested by the requesting provider by reviewing and considering the requesting provider's recommendation, the enrollee's medical or other clinical history, as applicable, and individual clinical circumstances. Artificial intelligence (AI) shall not be the sole means used to deny, delay, or modify health care services. Algorithms may be used to process and approve prior authorization requests, but may not be used without human review to deny care based on a determination of medical necessity.

 

A carrier or health plan and any contracted health care benefit manager that uses AI for the purpose of prior authorization or prior authorization functions, based in whole or in part on medical necessity, or that contracts with or otherwise works through a third party for these purposes, shall ensure all of the following: 

  • the AI bases its determination on the following information, as applicable:
    1. an enrollee's medical or other clinical history;
    2. individual clinical circumstances as presented by the requesting provider; and
    3. other relevant clinical information contained in the enrollee's medical or other clinical record; 
  • the AI does not base its determination solely on a group data set;
  • the AI criteria and guidelines complies with this act and applicable state and federal law;
  • the use of AI does not discriminate, directly or indirectly, against an enrollee in violation of state or federal law;
  • the AI is fairly and equitably applied, including in accordance with any applicable regulations and guidance issued by the federal Department of Health and Human Services;
  • the policies and procedures for using AI is open to audit by OIC;
  • the AI performance, use, and outcomes are periodically reviewed to maximize accuracy and reliability; and
  • patient data is not used beyond its intended and stated purpose, consistent with state and federal law. 

 

Carrier Retrospective Denials. Carriers shall not retrospectively deny coverage or retrospectively modify to a service less intensive than that included in the approved request for emergency and nonemergency care that had prior authorization, including for medical necessity, under the plan's written policies at the time the care was rendered, unless the approved prior authorization was based upon a material misrepresentation by the provider, facility, or covered person or the underlying health plan coverage is lawfully rescinded, canceled, or terminated retrospectively through the date of service.  

 

Retrospective denials of services with an approved prior authorization or retrospective modification of an approved prior authorization to less intensive services due to a change in the carrier's determination of medical necessity are prohibited, shall not be considered adverse benefit determinations, and will not be required to follow the standard appeals processes. If an enrollee, or the provider requesting the authorization demonstrates the authorization was valid per the plan's written policies, then the carrier will deem the authorization approved and payable. Interest will be assessed on the associated claim submitted by the provider at the rate of 1 percent per month, retroactive to the date of submission. An enrollee, or provider on behalf of the enrollee, may seek review by an independent review organization without the need to engage in, exhaust, or wait for any timelines related to the carrier's grievance process.

 

By October 1, 2026, carriers also must report the total number of prior authorization requests, approvals, and denials made in that time. The carrier must report these totals by both health plan and each health care benefit manager that is delegated to provide care determinations on behalf of the carrier. In the report, carriers must also indicate the percentage of total denials that were aided by AI and the percent of care determinations made after the required emergent and nonemergent authorization request turnaround times.

 

The OIC must annually submit a report detailing the trend data for total prior authorization requests, approvals, and denials submitted by carriers separately for each carrier directly and for each health care benefit manager that is delegated to make prior authorization determinations either directly or indirectly on behalf of the carrier.

Votes on Final Passage:
Final Passage Votes
Senate 48 1
House 94 0 (House amended)
Senate 49 0 (Senate concurred)
Effective:

June 11, 2026

January 1, 2027 - Sections 3 and 7